OLMA Olema Pharmaceuticals, Inc.
Biotechnology NasdaqGS
Trading Signals (OLMA)
Overall Signal
BUY
Strong buyish signal based on multiple indicators.
Key Price Levels
Support Levels
- Strong Support $4.31
- Medium Support $4.59
- Weak Support $4.86
Resistance Levels
- Weak Resistance $5.42
- Medium Resistance $5.69
- Strong Resistance $5.96
Stop Loss Suggestions
- Conservative $4.46
- Moderate $4.73
- Aggressive $4.45
Analyst Ratings
Current Rating
Signal Indicator
| Indicator | Signal | Strength | Timeframe |
|---|---|---|---|
| Moving Averages | BUY |
|
Short & Medium Term |
| Oscillators | BUY |
|
Short Term |
| Trend Indicators | BUY |
|
Short & Medium Term |
| Volume Indicators | BUY |
|
Short & Medium Term |
| Support/Resistance | NEUTRAL |
|
Short Term |
Stock Price Prediction Price Target Probabilities (OLMA)
Quarterly Outlook :
2026-02-09
Bullish Scenario
from current 26.46%
Strong upward momentum and confirmed bullish trend, with potential for significant price appreciation. Indicators point to sustained buying pressure. ADX (13.76) indicates a weak or ranging trend. Market is likely in a consolidation or range-bound phase. RSI (49.68) is in bearish territory, indicating downward momentum. MACD line (-0.31) is above Signal line (-0.53) (bullish crossover), confirming upward momentum. Current Weekly ATR is 0.68, indicating the average weekly price range.
2026-02-09
Base Scenario
from current 3.31%
Price is likely to continue its moderate trajectory, reflecting underlying market conditions and historical volatility. Indicators suggest a balanced outlook. ADX (13.76) indicates a weak or ranging trend. Market is likely in a consolidation or range-bound phase. RSI (49.68) is in bearish territory, indicating downward momentum. MACD line (-0.31) is above Signal line (-0.53) (bullish crossover), confirming upward momentum. Current Weekly ATR is 0.68, indicating the average weekly price range.
2026-02-09
Bearish Scenario
from current -26.46%
Increased selling pressure and potential for a significant price correction or downtrend. Indicators suggest waning bullish momentum or strengthening bearish forces. ADX (13.76) indicates a weak or ranging trend. Market is likely in a consolidation or range-bound phase. RSI (49.68) is in bearish territory, indicating downward momentum. MACD line (-0.31) is above Signal line (-0.53) (bullish crossover), confirming upward momentum. Current Weekly ATR is 0.68, indicating the average weekly price range.
Annual Outlook
2026-02-09
Bullish Scenario
from current 52.92%
Long-term bullish trend with strong fundamental catalysts and sustained institutional buying. Expect significant capital appreciation over the year. ADX (13.76) indicates a weak or ranging trend. Market is likely in a consolidation or range-bound phase. RSI (49.68) is in bearish territory, indicating downward momentum. MACD line (-0.31) is above Signal line (-0.53) (bullish crossover), confirming upward momentum. Current Weekly ATR is 0.68, indicating the average weekly price range.
2026-02-09
Base Scenario
from current 6.61%
Steady long-term growth consistent with market and industry averages. Price expected to follow a typical growth trajectory. ADX (13.76) indicates a weak or ranging trend. Market is likely in a consolidation or range-bound phase. RSI (49.68) is in bearish territory, indicating downward momentum. MACD line (-0.31) is above Signal line (-0.53) (bullish crossover), confirming upward momentum. Current Weekly ATR is 0.68, indicating the average weekly price range.
2026-02-09
Bearish Scenario
from current -52.92%
Long-term bearish trend with significant headwinds from economic factors, industry disruption, or company-specific issues. Expect notable price depreciation. ADX (13.76) indicates a weak or ranging trend. Market is likely in a consolidation or range-bound phase. RSI (49.68) is in bearish territory, indicating downward momentum. MACD line (-0.31) is above Signal line (-0.53) (bullish crossover), confirming upward momentum. Current Weekly ATR is 0.68, indicating the average weekly price range.
Technical Analysis (OLMA)
Trend Identification
EMA
Exponential Moving Average
Current price (5.14) is above both Short MA (4.71) and Long MA (4.61). This indicates strong bullish momentum. Short MA (4.71) is above Long MA (4.61), a bullish crossover ('Golden Cross' if it's a significant period). This indicates an upward trend. All MAs are in bullish order (Price > Short MA > Long MA > Very Long MA 4.47). This is a strong bullish alignment. Consider long positions. Use the MAs as dynamic support levels.
MACD
Moving Average Convergence Divergence
MACD line is above the Signal line (bullish crossover). This indicates upward momentum. Histogram (0.0600) is positive and expanding, confirming bullish momentum. Both MACD and Signal lines are above the zero line, reinforcing bullish momentum (bullish territory). This is a strong buy signal. Consider long positions.
ADX
Average Directional Index
ADX (13.57) indicates a weak or non-existent trend (ranging market). +DI (24.89) is above -DI (10.84), suggesting a bullish directional bias. Avoid trend-following strategies. Consider range-bound or reversal strategies, or wait for a clearer trend to develop.
Momentum Measurement
RSI (2026-02-09)
Relative Strength Index
RSI (63.17) is in the bullish territory, but not yet overbought. This indicates upward momentum. Monitor for continuation or signs of weakness.
OBV (2026-02-09)
On-Balance Volume
OBV (4144145.00) is rising, indicating buying pressure and accumulation. Price is rising and OBV is rising. This is bullish confirmation, indicating buying pressure supports the price increase. Consider holding long positions or initiating new ones. Volume is supporting the trend.
Stochastic (2026-02-09)
Stochastic Oscillator
Stochastics (%K: 79.59, %D: 82.87) are in the neutral zone (between 20 and 80). A bearish crossover (%K below %D) is observed, potentially signaling a downward trend reversal or continuation. Stronger signal if this occurs above 50.
CCI (2026-02-09)
Commodity Channel Index
CCI (162.00) is above +100. This suggests a strong upward momentum and an overbought condition. Consider profit-taking or looking for short entries cautiously. Confirm with price action; if price is making higher highs, momentum is strong. Look for pullbacks to enter long.
Volatility Measurement
ATR (2026-02-09)
Average True Range
Current ATR is 0.2900. ATR indicates average volatility. Market conditions are relatively stable.
Bollinger Bands (2026-02-09)
Volatility Bands
Current price (5.14) is above the Upper Bollinger Band (5.13). This often indicates an overextended move and a potential reversal downwards, or strong upward momentum ('walking the band'). Bollinger Bands are wide. This indicates high volatility. Prices tend to revert to the mean after extended periods of high volatility. Consider shorting or taking profit on long positions, but confirm with other indicators.
Risk Management & Potential Reversals (OLMA)
SAR (2026-02-09)
Parabolic Stop and Reverse
SAR points below price indicate bullish trend. Current SAR at 4.46 is 13.23% from price. Consider SAR as a potential stop-loss level to protect gains in an uptrend.
Stochastic (2026-02-09)
Approaching Overbought
Stochastic is approaching overbought territory (79.6). No reversal signal yet. Monitor for potential bearish crossover (K below D) or entry into overbought (80+) followed by reversal. Current crossover status: Bearish.
RSI (2026-02-09)
Reversal Perspective
Current RSI level is in neutral territory. No RSI divergence detected. Current RSI level doesn't suggest imminent reversal.
Bollinger Bands (2026-02-09)
Reversal Perspective
Bollinger Bands are widening, indicating high volatility and potential strong trend continuation.Price is above the upper band, indicating overbought conditions or strong upward momentum. Expect a potential pullback or trend exhaustion.No indication of imminent volatility expansion or reversal.
Holder List Top 20 (OLMA)
| Holder Name | Holder Type | Shares | Pct. Held | Date Reported |
|---|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | INSTITUTIONAL | 6843954 | 10.01% | 2025-03-31 |
| Paradigm Biocapital Advisors LP | INSTITUTIONAL | 6741172 | 9.86% | 2025-03-31 |
| BVF Inc. | INSTITUTIONAL | 5295893 | 7.75% | 2025-03-31 |
| Blackrock Inc. | INSTITUTIONAL | 3822342 | 5.59% | 2025-03-31 |
| Deep Track Capital, Lp | INSTITUTIONAL | 3442833 | 5.04% | 2025-03-31 |
| Logos Global Management LP | INSTITUTIONAL | 3208875 | 4.69% | 2025-03-31 |
| Franklin Resources, Inc. | INSTITUTIONAL | 3011969 | 4.41% | 2025-03-31 |
| MPM BIOIMPACT LLC | INSTITUTIONAL | 2930446 | 4.29% | 2025-03-31 |
| Vanguard Group Inc | INSTITUTIONAL | 2871613 | 4.2% | 2025-03-31 |
| Lightspeed Management Company, L.L.C. | INSTITUTIONAL | 1930894 | 2.82% | 2025-03-31 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | MUTUALFUND | 1630966 | 2.39% | 2025-03-31 |
| iShares Trust-iShares Russell 2000 ETF | MUTUALFUND | 1007347 | 1.47% | 2025-04-30 |
| Franklin Strategic Series-FRANKLIN SMALL CAP GROWTH FUND | MUTUALFUND | 893200 | 1.31% | 2025-01-31 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | MUTUALFUND | 816315 | 1.19% | 2025-03-31 |
| Franklin Strategic Series-FRANKLIN BIOTECHNOLOGY DISCOVERY FUND | MUTUALFUND | 772189 | 1.13% | 2025-01-31 |
| Columbia Funds Series Trust I-Columbia Small Cap Value Fund I | MUTUALFUND | 523190 | 0.77% | 2025-01-31 |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | MUTUALFUND | 408462 | 0.6% | 2025-02-28 |
| iShares Trust-iShares Biotechnology ETF | MUTUALFUND | 339644 | 0.5% | 2025-04-30 |
| iShares Trust-iShares Russell 2000 Value ETF | MUTUALFUND | 298711 | 0.44% | 2025-04-30 |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | MUTUALFUND | 266405 | 0.39% | 2025-04-30 |